17:51 IST
BSE
Other Announcement
Bafna Pharmaceuticals Other Announcement
Bafna Pharmaceuticals has filed its quarterly shareholding pattern as of June 30, 2026, in compliance with SEBI LODR regulations.
Bafna Pharmaceuticals Ltd
- Share price
- ₹401.85
- Market cap
- ₹950.6 Cr
- Revenue (annual)
- ₹150.6 Cr
- Net profit (annual)
- ₹11.10 Cr
- P/E (TTM)
- 122.1×Sector 47.4×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 9.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 3Board Meeting Date 2Annual General Meeting 2Price Movement Clarification 1Other Announcement 1Annual Report 1
Time
1 announcement with these filters